首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 體外診斷設備 > 次世代免疫測量:市場與技術分析
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

次世代免疫測量:市場與技術分析

Next-Generation Immunoassays: A Market and Technical Analysis of Research Applications 07

出版商 Select Biosciences, Ltd.
出版日期 2007年12月 商品編碼 60568
內容資訊 英文 Pages: 179
價格
US $ 4290 PDF By E-mail (Site License)


次世代免疫測量:市場與技術分析 是由出版商Select Biosciences, Ltd.在2007年12月所出版的。 這份英文市場調查報告書包含Pages: 179 價格從美金4290起跳。

簡介

此報告書中以免疫測量的市場機會與課題、技術等為中心進行調查。報告書之內容摘要如下所示。

第1章 摘要

第2章 免疫測量的說明

  • 說明
  • 免疫測量種類
    • 免疫印記法
    • 免疫沉澱
    • 酵素免疫測量(ELISA)
    • 抗體配置
    • 免疫組織化學

第3章 次世代技術的機會與課題

  • 敏感性
  • 準確性
  • 內容
  • 多樣化

第4章 市場模式

  • 整體市場
    • 市場發展因素
    • 市場規模
    • 整體市場
    • ELISA
    • 免疫印記法
    • 免疫沉澱
    • 抗體配置
    • 其他
    • 各構成要素統計

第5章 企業概況

  • 配置企業
  • 抗體企業
  • 即時檢測裝置企業
  • 增幅裝置企業

目錄

Abstract

The immunoassay assay is undergoing a major makeover. New amplification methods offer the promise to peer deeper into the proteome; new detection methods offer the promise to see clearer; new multiplexing to look faster and more efficiently; and new content to observe farther. These new technologies are addressing significant unmet needs in sensitivity, accuracy, speed, cost and breadth.

This new report details the opportunities and challenges in a market valued at more than $1.1 billion in 2003 and projected to grow to more than $2.2 billion in 2012. The report is based on surveys of researchers and thorough evaluations of more than 70 technologies encompassing novel antibody generation, real-time detection, new amplification methods and multiplexed antibody arrays. The financial projections are based on a 3 by 5 market matrix model encompassing instruments, antibodies and other reagents and consumables across ELISAs, Western blots, immunoprecipitations, antibody arrays and novel antibody characterization methods.

In addition, the report comes with an hour of discussion (pending availability and limited to a conference call format) with Steven Bodovitz, Principal of BioPerspectives, or Jutta Bachmann, CEO of Bachmann Consulting.

Table of Contents

Table of contents

Chapter 1: Executive Summary

Chapter 2: Introduction to Immunoassays

  • Introduction
  • Types of Immunoassays
    • Western Blots
    • Immunoprecipitation
    • ELISAs
    • Antibody Arrays
    • Immunohistochemistry
    • Detection
    • Immunoassay Characterization

Chapter 3: Opportunities and Challenges for Next-Generation Technologies

  • Sensitivity
  • Accuracy
  • Content
  • Multiplexing

Chapter 4: Market Model

  • Overall Market
    • Market Drivers
    • Market Sizes
    • Total Market
    • ELISAs
    • Western Blots
    • Immunoprecipitations
    • Antibody Arrays
    • Other Characterization
    • Total By Component

Chapter 5: Company Profiles

  • Array companies
    • Abbott Molecular, Inc.
    • Applied Biosystems
    • Bangs Laboratories
    • Beckman Coulter, Inc.
    • Bender Medsystems GmbH
    • Biocept, Inc.
    • Bio-Rad Laboratories
    • Bioarray Solutions, Ltd.
    • Biosource International
    • bmd - BioMedical Diagnostics
    • DiagnoSwiss S.A.
    • GenTel Biosciences, Inc.
    • Gyros AB
    • Hypromatrix, Inc.
    • Illumina, Inc.
    • Invitrogen Corporation
    • Luminex Corporation
    • Marligen Biosciences, Inc.
    • Merck Chemicals Ltd./EMD Chemicals, Inc
    • Meso Scale Discovery
    • Microbionix GmbH
    • Millipore Corporation
    • Upstate Group LLC (now part of Millipore)
    • MiraiBio, Inc.
    • Multimetrix GmbH
    • One Lambda, Inc.
    • Osmetech Inc./plc
    • Perbio Science
    • PerkinElmer, Inc.
    • Protagen AG
    • Radix BioSolutions
    • Randox Laboratories Ltd.
    • RayBiotech, Inc.
    • Rules-Based Medicine, Inc.
    • Sigma-Aldrich Corporation
    • US Biomax, Inc.
    • VBC-GENOMICS Bioscience Research GmbH
    • Whatman plc
    • Zeus Scientific, Inc.
  • Antibody companies
    • Affibody AB
    • AbD Serotec, a Division of MorphoSys
    • Aspira Biosystems, Inc.
    • Domantis
    • Eurogentec S.A.
    • Epitome Biosystems
    • Epitomics, Inc.
    • Human Protein Atlas
    • Imgenex Corporation
    • Primorigen Biosciences LLC
    • R&D Systems, Inc.
  • Real-time detection companies
    • ACEA Biosciences
    • Axela Biosensors, Inc.
    • Biodesy, LLC
    • Bioforce Nanosciences, Inc.
    • Cell Biosciences
    • Corning Incorporated
    • CSEM SA
    • Farfield Scientific
    • ForteBio Inc.
    • GE Healthcare (formerly Biacore International AB)
    • GWC Technologies, Inc
    • Plexera Bioscience LLC
    • MDS Sciex
    • SRU Biosystems
  • Amplification companies
    • American Dye Source
    • BioPAL, Inc.
    • BioVeris Corporation (now part of Roche)
    • Chimera Biotec GmbH
    • Dendritic Nanotechnologies, Inc.
    • Evident Technologies
    • Lumiphore, Inc
    • Monogram Biosciences, Inc
    • Nanosphere, Inc.
    • Olink Bioscience
    • QIAGEN N.V./GmbH
    • SRI International

Author credentials

Glossary

Index

Back to Top